Veneno Technologies, a Novel Bio-Active DRP Discovery Company, has entered into a joint research agreement with KYORIN Pharmaceutical Co., Ltd. For more information, please click here.

Veneno Technologies Co., Ltd. has been certified as an AISol Startup. For more information, please click here.

Veneno Technologies, a Novel DRP Drug Discovery Company, has entered into a joint research agreement with Sumitomo Pharma Co. Ltd. For more information, please click here.

Veneno Technologies, a Novel DRP Drug Discovery Company, has entered into a joint research agreement with Astellas Pharma Inc. For more information, please click here.

Veneno Technologies will exhibit at Blockbuster TOKYO Lifescience Startup career fair 2023. Blockbuster TOKYO Lifescience Startup career fair 2023

Veneno Technologies will participate in the Global life science pitch +mentorship event. Dr. Taira, Director, will be on stage on the day. Global life science pitch +mentorship event

The 1st Veneno Technologies Seminar – Introduction to Environmentally Friendly Next Generation Peptide Pesticides – was held.During the seminar, three distinguished researchers presented various aspects of the potential for peptide pesticide development. Dr. Masahiro Miyashita, Associate Professor, Graduate School of Agriculture, Kyoto University Dr. Tomohisa Ogawa, Professor, Graduate School of Agricultural Science, Tohoku University Dr. […]

Veneno Technologies will participate in AIST Startup Pitch – Startup Alumni Association from AIST. Dr. Kimura, Director, will speak at the event. (CIC, Tokyo) Startup Alumni Association from AIST

Our company was interviewed and introduced by “JSTORIES”, a bilingual media that introduces new innovations by Japanese companies to the world.Entitled, From lethal poison to life-saving panacea – Japanese company’s new tech platform and genetic library aims to make medicine from animal venom – JSTORIES

Veneno Technologies will participate in the 11th DSANJ (Drug Seeds Alliance Network Japan) Digital Bio Conference 2023 hosted by AMED, Japan Pharmaceutical Manufacturers Association, and Osaka Chamber of Commerce and Industry.

Veneno Technologies will participate in Kansai Bio Business Matching 2022. On the day of the event, Dr. Matsukawa, Director, will make a pitch introducing our company.

Veneno Technologies will participate in the 13th annual meeting of Conference on Biomolecular Screenology (Funabori, Tokyo). Dr. Taira, Director, will give a poster presentation at the meeting, entitled Rapid screening of disulfide-rich peptides with ion channel Nav1.7 inhibitory activity by PERISS method.